These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Sui X, Krantz SB, You M, Zhao Z. Blood; 1998 Aug 15; 92(4):1142-9. PubMed ID: 9694701 [Abstract] [Full Text] [Related]
3. The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells. Paiboonsukwong K, Choi I, Matsushima T, Abe Y, Nishimura J, Winichagoon P, Fucharoen S, Nawata H, Muta K. Int J Hematol; 2003 Dec 15; 78(5):421-8. PubMed ID: 14704034 [Abstract] [Full Text] [Related]
4. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors. Uddin S, Kottegoda S, Stigger D, Platanias LC, Wickrema A. Biochem Biophys Res Commun; 2000 Aug 18; 275(1):16-9. PubMed ID: 10944433 [Abstract] [Full Text] [Related]
9. PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors. Schmidt EK, Fichelson S, Feller SM. BMC Biol; 2004 May 18; 2():7. PubMed ID: 15149544 [Abstract] [Full Text] [Related]
10. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling. Mori M, Uchida M, Watanabe T, Kirito K, Hatake K, Ozawa K, Komatsu N. J Cell Physiol; 2003 May 18; 195(2):290-7. PubMed ID: 12652655 [Abstract] [Full Text] [Related]
11. Unraveling distinct intracellular signals that promote survival and proliferation: study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells. Sawyer ST, Jacobs-Helber SM. J Hematother Stem Cell Res; 2000 Feb 18; 9(1):21-9. PubMed ID: 10738968 [Abstract] [Full Text] [Related]
12. Opposing effects of PI3 kinase pathway activation on human myeloid and erythroid progenitor cell proliferation and differentiation in vitro. Lewis JL, Marley SB, Ojo M, Gordon MY. Exp Hematol; 2004 Jan 18; 32(1):36-44. PubMed ID: 14725899 [Abstract] [Full Text] [Related]
13. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Haseyama Y, Sawada Ki, Oda A, Koizumi K, Takano H, Tarumi T, Nishio M, Handa M, Ikeda Y, Koike T. Blood; 1999 Sep 01; 94(5):1568-77. PubMed ID: 10477682 [Abstract] [Full Text] [Related]
14. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways. Huang HM, Huang CJ, Yen JJ. Blood; 2000 Sep 01; 96(5):1764-71. PubMed ID: 10961875 [Abstract] [Full Text] [Related]
15. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST. Blood; 1999 Jun 01; 93(11):3757-73. PubMed ID: 10339482 [Abstract] [Full Text] [Related]
16. Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors. Geslain R, Uddin S, Liu H, Jiang H, van Besien K, Pan T, Wickrema A. Cytokine; 2013 Jan 01; 61(1):329-35. PubMed ID: 23148990 [Abstract] [Full Text] [Related]
17. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. Chaudhary LR, Hruska KA. J Cell Biochem; 2001 Mar 26; 81(2):304-11. PubMed ID: 11241670 [Abstract] [Full Text] [Related]
18. Biochemical measurements on single erythroid progenitor cells shed light on the combinatorial regulation of red blood cell production. Wang W, Akbarian V, Audet J. Mol Biosyst; 2013 Feb 02; 9(2):234-45. PubMed ID: 23168618 [Abstract] [Full Text] [Related]
19. Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation. Laubach JP, Fu P, Jiang X, Salter KH, Potti A, Arcasoy MO. Exp Hematol; 2009 Dec 02; 37(12):1411-22. PubMed ID: 19815050 [Abstract] [Full Text] [Related]
20. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals. O'Gorman DM, McKenna SL, McGahon AJ, Knox KA, Cotter TG. Leukemia; 2000 Apr 02; 14(4):602-11. PubMed ID: 10764145 [Abstract] [Full Text] [Related] Page: [Next] [New Search]